Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.

Epidemiological studies have demonstrated that type 2 diabetes mellitus (T2DM) and hyperinsulinemia are associated closely with endometrial carcinoma risk, although the molecular mechanism remains unclear. Insulin receptor isoformA expression is upregulated in many cancer cells and tissues, which su...

Full description

Bibliographic Details
Main Authors: Chun-Fang Wang, Guo Zhang, Li-Jun Zhao, Wen-Juan Qi, Xiao-Ping Li, Jian-Liu Wang, Li-Hui Wei
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3737217?pdf=render
id doaj-9887dfa4c3d447f9a1ad00c856c851ba
record_format Article
spelling doaj-9887dfa4c3d447f9a1ad00c856c851ba2020-11-25T01:32:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0188e6900110.1371/journal.pone.0069001Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.Chun-Fang WangGuo ZhangLi-Jun ZhaoWen-Juan QiXiao-Ping LiJian-Liu WangLi-Hui WeiEpidemiological studies have demonstrated that type 2 diabetes mellitus (T2DM) and hyperinsulinemia are associated closely with endometrial carcinoma risk, although the molecular mechanism remains unclear. Insulin receptor isoformA expression is upregulated in many cancer cells and tissues, which suggests that IR-A-mediated signaling pathways may have important implications for cancer pathogenesis. We measured the expression of insulin receptor isoforms (IR-A and IR-B in the normal endometrium tissues, the endometrial carcinoma tissues and the endometrial carcinoma cell lines. We found that the total insulin receptor (IR) and IR-A expression mRNA levels and the ratio of IR-A to total IR in endometrial carcinoma specimens were significantly higher than them in control endometrial tissue specimens(P<0.05). Further analysis indicated that the tendency was more prominently in patients with T2DM. IR-A mRNA was differentially expressed in four endometrial carcinoma cell lines (Ishikawa, KLE, RL95-2 and HEC-1-A. RL95-2 cells have a low endogenous IR-A expression, and these were used to construct a stable cell line overexpressing IR-A. We found that IR-A overexpression significantly increased cell proliferation, the proportion of cells in S phase, activation of the Akt pathway and tumorigenicity of xenografts in nude mice. In contrast, there was no significant difference in the the percentage of apoptotic cells between cells overexpressing IR-A and control cells. Moreover, levels of phosphorylated ERK1/2 protein were significantly decreased in cells overexpressing IR-A relative to controls. These findings reveal the pivotal role of IR-A in endometrial cancer carcinogenesis, and suggest that the association of elevated IR-A levels with cell proliferation and tumorigenicity may be causally linked to its effect on the proportion of cells in S phase and the activation of the Akt pathway.http://europepmc.org/articles/PMC3737217?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Chun-Fang Wang
Guo Zhang
Li-Jun Zhao
Wen-Juan Qi
Xiao-Ping Li
Jian-Liu Wang
Li-Hui Wei
spellingShingle Chun-Fang Wang
Guo Zhang
Li-Jun Zhao
Wen-Juan Qi
Xiao-Ping Li
Jian-Liu Wang
Li-Hui Wei
Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.
PLoS ONE
author_facet Chun-Fang Wang
Guo Zhang
Li-Jun Zhao
Wen-Juan Qi
Xiao-Ping Li
Jian-Liu Wang
Li-Hui Wei
author_sort Chun-Fang Wang
title Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.
title_short Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.
title_full Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.
title_fullStr Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.
title_full_unstemmed Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.
title_sort overexpression of the insulin receptor isoform a promotes endometrial carcinoma cell growth.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Epidemiological studies have demonstrated that type 2 diabetes mellitus (T2DM) and hyperinsulinemia are associated closely with endometrial carcinoma risk, although the molecular mechanism remains unclear. Insulin receptor isoformA expression is upregulated in many cancer cells and tissues, which suggests that IR-A-mediated signaling pathways may have important implications for cancer pathogenesis. We measured the expression of insulin receptor isoforms (IR-A and IR-B in the normal endometrium tissues, the endometrial carcinoma tissues and the endometrial carcinoma cell lines. We found that the total insulin receptor (IR) and IR-A expression mRNA levels and the ratio of IR-A to total IR in endometrial carcinoma specimens were significantly higher than them in control endometrial tissue specimens(P<0.05). Further analysis indicated that the tendency was more prominently in patients with T2DM. IR-A mRNA was differentially expressed in four endometrial carcinoma cell lines (Ishikawa, KLE, RL95-2 and HEC-1-A. RL95-2 cells have a low endogenous IR-A expression, and these were used to construct a stable cell line overexpressing IR-A. We found that IR-A overexpression significantly increased cell proliferation, the proportion of cells in S phase, activation of the Akt pathway and tumorigenicity of xenografts in nude mice. In contrast, there was no significant difference in the the percentage of apoptotic cells between cells overexpressing IR-A and control cells. Moreover, levels of phosphorylated ERK1/2 protein were significantly decreased in cells overexpressing IR-A relative to controls. These findings reveal the pivotal role of IR-A in endometrial cancer carcinogenesis, and suggest that the association of elevated IR-A levels with cell proliferation and tumorigenicity may be causally linked to its effect on the proportion of cells in S phase and the activation of the Akt pathway.
url http://europepmc.org/articles/PMC3737217?pdf=render
work_keys_str_mv AT chunfangwang overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth
AT guozhang overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth
AT lijunzhao overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth
AT wenjuanqi overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth
AT xiaopingli overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth
AT jianliuwang overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth
AT lihuiwei overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth
_version_ 1725083122206244864